Michael Bodd is a Partner and co-founder of Serendipity Partners. Prior to joining Serendipity Partners in 2016, Michael was a management consultant with Boston Consulting Group and a Principal in the private equity firm Lindsay Goldberg Nordic.

Through his consulting experience, directorships and as an investor, Michael holds deep experience from various healthcare sectors including service providers, pharma, medtech, e-health, CRO, biotech and diagnostics.

Michael holds a PhD in immunology and has spent five years doing basic research within the field of immunology. He has also worked as a medical doctor both in hospital and general practice.